Reuters Events Pharma’s Post

I thoroughly enjoyed listening to Samm Zombolo, Sanjeev Welling and Avira Digital discussing the evolution of medical affairs! What are your thoughts on the evolution of medical affairs?

In this week's episode of Redefining Evidence Management, we have Samm Zombolo, Senior Vice President of Medical Affairs and HEOR at EPM Scientific, discussing her unique journey into medical affairs. Samm shares her insights on the transformative impact of digital advancements and AI on the pharmaceutical and biotech industries. Discover how integrating technology is reshaping medical affairs and the importance of adaptability in this fast-evolving field. Join us as Samm explores the future of medical affairs, the integration of strategic development, and the role of patient-centric approaches in modern healthcare. #RedefiningMedicalAffairs #PharmaInnovation #AIinHealthcare #DigitalTransformation

So many of you in my network already know Samm Zombolo, so I know this will be of interest! Samm had a great conversation about the current state of medical affairs and where we're going. Give a listen and let us know your thoughts! #medicalaffairs

Have you already signed up for our free 4C Close-up webinar! 😀 Topic: C3-Clinical Studies | How to certify a large language model as a medical device?

Psyched to welcome Colin Riessen who has joined Peer as our Global Head of Medical Writing! His expertise and vision have already had a deep impact as we design the #GenerativeAI solutions that are transforming regulatory medical writing and we're just getting started. 🎉🚀 #RegulatoryMedicalWriting #GenerativeAI #PeerAI #NewHire

⏳ Ending at midnight tonight: Save $100 off your pass 👉 Data Driven, Hybrid and Full Decentralized Clinical Trials 📍 Philadelphia this April, 16-17, 2024! Join your clinical community as we put the patient at the forefront of clinical trials to help you increase engagement and improve data quality Join a rich line up of speakers from Sanofi, Astellas Pharma, Moderna, Takeda, Bayer, Novartis and many more to learn first-hand the latest hybrid and decentralized strategies including: ✅ How to leverage AI to integrate systems, ✅ Frontier based trials ✅ Tools to broaden clinical trials participant diversity, equity and inclusion ✅ Rural site management 👉 Do you work in Pharma/Biotech? Join for free in Philadelphia here: https://lnkd.in/e4WbB3Wy 👉 View the full agenda: https://lnkd.in/ecth-FKw #ClinicalTrials #ClinicalInnovation #DCT #DecentralizedTrials #HybridTrials

How do you track progress and measure success during market shaping? There are no sales to measure, so what kind of indicators should be monitored to gauge that we are on the path to success? This is one of the topics we discussed in this recent CapSys Group panel discussion. Hear the thoughts of: - Luca Gazzi, Global Market Access & Pricing Lead at Sanofi - Klaus Viel, Innovation Leader Early Medical Affairs, Integrated Planning, and brand-agnostic services at Boehringer Ingelheim - Siddharth Jain, Medical Director, Global Medical Lead (Lysosomal Storage Diseases) at Takeda Thanks to all of you for sharing your insights with us - and, as ever, would welcome everyone's thoughts in the comments below. #Biopharma #PharmaceuticalIndustry #Webinar

Excited to share a new milestone achieved! I, just earned my certification in Design and Interpretation of Clinical Trials, delving into the fascinating world of clinical research. From crafting robust protocols to deciphering complex trial data, this journey has equipped me with the skills to drive evidence-based decisions in the realm of healthcare and pharmaceuticals. Looking forward to applying this knowledge to contribute meaningfully to the advancement of medical science and patient well-being. #ClinicalTrialCertification #ResearchExcellence #HealthcareInnovation

In our latest case study, we explore the impact A Life in a Day has had among Patient Advocates at a global scale. Read on to explore the transformable impact of bringing powerful patient experiences into the forefront of what your teams do.   https://ow.ly/8HSr50QtFsH #PatientEngagement #HealthcareAdvocacy #Pharma 

❓ How do you cluster markets effectively, especially in Europe? An important question when thinking about pre-launch market shaping in Biopharma. We discussed this in our recent CapSys Group panel discussion. In this short video clip, you can hear the thoughts of: - Luca Gazzi, Global Market Access & Pricing Lead at Sanofi - Klaus Viel, Innovation Leader Early Medical Affairs, Integrated Planning, and brand-agnostic services at Boehringer Ingelheim - Siddharth Jain, Medical Director, Global Medical Lead (Lysosomal Storage Diseases) at Takeda Our warm thanks to all of you for sharing your insights with us - and would welcome everyone's additional thoughts in the comments below. #Biopharma #PharmaceuticalIndustry #Webinar